Ursula Ehmer

8PUBLICATIONS

86CO-AUTHORS

Haematological tumoursCancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|May 19, 2026

Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI Registry.

|Apr 18, 2026

Development and Release of the Munich UICC Staging Tool (MUST): Advancing UICC Staging in Real-World Data With Insights From Pancreatic and Stomach Cancer.

|May 12, 2025

Activation of RAS/MEK/ERK signalling drives biliary differentiation in primary liver cancer.

Thomas Rösner, Carina Rupp, Christian Lechler

|Mar 28, 2025

Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study.

Christian Möhring, Moritz Berger, Farsaneh Sadeghlar

|Nov 04, 2024

Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort.

Tiago de Castro, Sabrina Welland, Leonie Jochheim

|Jul 29, 2023

Fulminant Liver Failure after Treatment with a Checkpoint Inhibitor for Gastric Cancer: A Case Report and Review of the Literature.

Miriam Dibos, Johanna Dumoulin, Carolin Mogler

Pageof 2

Frequent Collaborators

Najib Ben Khaled

Marino Venerito

Arndt Weinmann

Arndt Vogel

Bernhard Scheiner

Anna Saborowski

Maria A Gonzalez-Carmona

2 joint publications

Jens U Marquardt

2 joint publications

Sabrina Welland

2 joint publications

Dieter Saur

Frequent Collaborators

Najib Ben Khaled

Marino Venerito

Arndt Weinmann

Arndt Vogel